MATV
Mativ Holdings, Inc. · Materials · Specialty Chemicals
Last
$10.85
−$0.21 (−1.93%) 4:00 PM ET
After hours $10.84 −$0.01 (−0.06%) 8:43 PM ET
Prev close $11.06
Open $10.97
Day high $11.05
Day low $10.55
Volume 411,922
Avg vol 347,968
Mkt cap
$592.74M
P/E ratio
-1.75
FY Revenue
$1.99B
EPS
-6.21
Gross Margin
18.26%
Sector
Materials
AI report sections
MATV
Mativ Holdings, Inc.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+27% (Above avg)
Vol/Avg: 1.27×
RSI
33.91 (Weak)
Weak (30–40)
MACD momentum
Intraday
-0.00 (Weak)
MACD: -0.02 Signal: -0.02
Short-Term
-0.43 (Weak)
MACD: -0.44 Signal: -0.01
Long-Term
-0.34 (Weak)
MACD: -0.10 Signal: 0.24
Intraday trend score 51.00

Latest news

MATV 12 articles Positive: 1 Neutral: 1 Negative: 0
Neutral The Motley Fool • Jesterai
Mativ (MATV) Q2 EPS Jumps 83%

Mativ reported Q2 2025 earnings beating analyst expectations with $0.33 non-GAAP EPS and $525.4 million revenue, representing a 0.3% year-over-year increase. Despite positive cash flow, the company continues to face profitability challenges with a net loss of $9.5 million.

MATV earnings financial performance manufacturing specialty materials filtration packaging
Sentiment note

Mixed financial performance with positive aspects like beating earnings expectations and strong free cash flow, but ongoing challenges with profitability, GAAP losses, and margin pressures in certain segments

Positive GlobeNewswire Inc. • N/A
U.S. Thermoplastics, Resins, Polymers, Plastics, Performance Materials and Synthetic Rubber Manufacturing Industry - Analytics, Financial Benchmarks, Metrics and Revenue Forecasts to 2030

The U.S. Thermoplastics, Resins, Polymers, Plastics, Performance Materials, and Synthetic Rubber Manufacturing Industry is projected to reach $189,135,113,213 by 2030, with detailed financial data and benchmarks provided for the industry and top companies.

CE EMN HUN TSE thermoplastics resins polymers plastics
Sentiment note

The article mentions Mativ Holdings as one of the top companies profiled and ranked, indicating it is a key player in the industry.

Unknown Zacks Investment Research • Zacks Equity Research
Rayonier Advanced Materials (RYAM) Reports Q1 Loss, Misses Revenue Estimates

Rayonier Advanced Materials (RYAM) delivered earnings and revenue surprises of -100% and 19.67%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

RYAM MATV
Unknown Zacks Investment Research • Zacks Equity Research
MATV vs. NVZMY: Which Stock Should Value Investors Buy Now?

MATV vs. NVZMY: Which Stock Is the Better Value Option?

MATV NVZMY
Unknown Zacks Investment Research • Zacks Equity Research
MATV or NVZMY: Which Is the Better Value Stock Right Now?

MATV vs. NVZMY: Which Stock Is the Better Value Option?

MATV
Unknown Zacks Investment Research • Zacks Equity Research
Zacks Value Investor Highlights: Astronics, American Vanguard, Mativ, Quad/Graphics and Synchronoss

Astronics, American Vanguard, Mativ, Quad/Graphics and Synchronoss have been highlighted in this Investment Ideas article.

ATRO SNCR AVD QUAD
Unknown Zacks Investment Research • Tracey Ryniec
5 Top Small Cap Stocks with Growth and Value

Why settle for only cheap small cap stocks? You can get growth too with this innovative screen.

ATRO SNCR AVD QUAD
Unknown Zacks Investment Research • Zacks Equity Research
MATV vs. NVZMY: Which Stock Is the Better Value Option?

MATV vs. NVZMY: Which Stock Is the Better Value Option?

MATV
Unknown Zacks Investment Research • Zacks Equity Research
Hawkins, Inc. (HWKN) Hit a 52 Week High, Can the Run Continue?

Hawkins (HWKN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

HWKN MATV
Unknown Zacks Investment Research • Zacks Equity Research
MATV vs. NVZMY: Which Stock Should Value Investors Buy Now?

MATV vs. NVZMY: Which Stock Is the Better Value Option?

MATV
Unknown Benzinga • Avi Kapoor
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Etsy, Inc. (NASDAQ: ETSY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Etsy reported quarterly earnings of 62 cents per share which missed the analyst consensus estimate of 78 cents. The company reported quarterly sales of $842.3 million, beating the analyst consensus estimate of $827.81 million. Etsy shares dipped 7.5% to $71.34 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers La Rosa Holdings Corp. (NASDAQ: LRHC) shares jumped 160.7% to $3.6499 after the company said it has acquired a 100% interest in the Company's franchisee - La Rosa Realty Winter Garden LLC located in Winter Garden, Florida. BuzzFeed, Inc. (NASDAQ: BZFD) jumped 91.4% to $0.4150 after the company revealed the sale of Complex Networks to NTWRK, a live-streaming video commerce platform. The deal, valued at $108.6 million, will also result in a 16% reduction in BuzzFeed’s workforce. Monopar Therapeutics Inc. (NASDAQ: MNPR) rose 80.7% to $1.03 after the company disclosed promising preclinical data for its MNPR-101 radiopharma program targeting advanced cancers. Root, Inc. (NASDAQ: ROOT) shares gained 40.8% to $12.21 after posting better-than-expected fourth-quarter results. Novavax, Inc. (NASDAQ: NVAX) jumped 34.7% to $5.36. Novavax has reached a settlement related to the 2021 advance purchase agreement for Novavax's prototype Covid-19 vaccine (NVX-COV2373). EZFill Holdings Inc. (NASDAQ: EZFL) rose 34.3% to $1.86. EzFill announced preliminary 2023 revenues of $23 million, up 54% year over year. Mercurity Fintech Holding Inc. (NASDAQ: MFH) jumped 30% to $2.93. Mativ Holdings, Inc. (NYSE: MATV) gained 27.6% to $15.00 following upbeat earnings. Venus Concept Inc. (NASDAQ: VERO) shares climbed 26.9% to $1.6242 after the company received CE Mark from DEKRA Certification B.V. to market Venus Versa Pro in Europe. Outset Medical, Inc. (NASDAQ: OM) gained 26% to $4.0680 following upbeat results. Ocular Therapeutix, Inc. (NASDAQ: OCUL) rose 22.2% to $9.19 after announcing a $325.0 million private ...

LRHC EAST GSHD INDV News Penny Stocks Small Cap Intraday Update
Unknown Benzinga • Avi Kapoor
NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday

U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday. Shares of NICE Ltd. (NASDAQ: NICE) rose sharply during Thursday’s session after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance above estimates. NICE reported fourth-quarter fiscal 2023 revenue growth of 9.6% year-over-year to $623.19 million, beating the consensus of $618.51 million. Adjusted EPS improved to $2.36 compared to $2.04 in the prior year, beating the consensus of $2.28. NICE shares jumped 10.4% to $249.39 on Thursday. Here are some other big stocks recording gains in today’s session. Root, Inc. (NASDAQ: ROOT) shares shares rose 40.8% to $12.21 after posting better-than-expected fourth-quarter results. Novavax, Inc. (NASDAQ: NVAX) gained 34.7% to $5.36. Novavax has reached a settlement related to the 2021 advance purchase agreement for Novavax's prototype Covid-19 vaccine (NVX-COV2373). Mativ Holdings, Inc. (NYSE: MATV) climbed 27.6% to $15.00 following upbeat earnings. Outset Medical, Inc. (NASDAQ: OM) rose 26% to $4.0680 following upbeat results. Ocular Therapeutix, Inc. (NASDAQ: OCUL) climbed 22.2% to $9.19 after announcing a $325.0 million private placement. Remitly Global, Inc. (NASDAQ: RELY) shares gained 19.5% to $21.13 after the company reported better-than-expected fourth-quarter ...

IBP QTWO ALTI OCUL News Penny Stocks Small Cap Intraday Update
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal